Results 101 to 110 of about 1,036 (190)
Background. Post-COVID syndrome is associated with a wide range of chronic symptoms or conditions. Coronavirus disease 2019 (COVID-19) causes metabolic disorders such as hyperglycemia, insulin resistance.
O.V. Kuryata +3 more
doaj +1 more source
Unsolved problems of cytoprotective therapy in patients with coronary heart disease
The paper gives data on the proven efficiency of myocardial cytoprotection with the pFOX inhibitors trimetazidine and meldonium for coronary heart disease.
M E Statsenko +2 more
doaj
Approaches in evaluation of freeze-dried antibody conjugates [PDF]
The presented experience was in freeze-drying of monoclonal antibody – rituximab, conjugated with three types of bifunctional chelating agents, p-SCN-Bn-DOTA, p-SCN-Bn-DTPA, and 1B4M-DTPA, and evaluation of possible changes in post-freeze-drying ...
Gjorgieva Ackova, Darinka +4 more
core
Age-related features of the pathogenesis of ischemic heart disease and sensitivity of patients’ DNA to cytoprotectors [PDF]
The high prevalence of coronary heart disease (CHD) and the increase in mortality from this nosology among patients of older age groups determine the urgency of the problem of improving the provision of medical care to this category of patients.
Alferov, P. K. +4 more
core
Potential Candidate Molecules of Past and Present for Combating High Altitude Hypoxia Induced Maladies [PDF]
Hypobaric hypoxia occurs at high altitudes where barometric pressure is low causing insufficient supply of oxygen leading to many high-altitude illnesses like acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), high altitude cerebral ...
Kushwaha, Shweta, Saraswat, Deepika
core +2 more sources
A procedure for simultaneous quantitative determination of meldonium, L-carnitine, and γ-butyrobetaine in blood plasma by high-performance liquid chromatography with mass-selective detection and the isotopically labeled d9L-carnitine as internal standard
P. N. Sorokoumov +4 more
doaj
AIM: To evaluate the impact of 10-14-day intravenous administration of meldonium as part of combination therapy in patients with chronic heart failure in the early post-infarction period on the recovery period, structural and functional parameters, and ...
M E Statsenko, N N Shilina, S V Turkina
doaj
Mildronate (meldonium): First, do no harm
Meldonium (Mildronate) is used as a cardioprotective drug; however, it has not been officially approved anywhere outside the former Soviet Union (SU). The supposed action mechanism is based on the carnitine (Lcarnitine) lowering effect in muscular and cardiac tissues.
openaire +1 more source
Performance-Enhancing Drugs: A Review [PDF]
Performance-enhancing drugs and substances have been an integral part of athletics and society. The immense popularity and financial compensation associated with success in sports often results in a desire to win at all costs, which stimulates a never ...
Gill, G Keith
core +1 more source
A tennis lesson : sharp practice in the science behind the Sharapova case [PDF]
Abrahamsson +11 more
core +1 more source

